GEHC Stock Price Rose $2.50 Intraday Amid Major Buying Pressure

GE HealthCare Technology (NASDAQ: GEHC) stock added $2.56 to its trading price in the June 30 trading session after it opened at $79.42, lowering to $79.31 and hitting a high of $81.41. It closed at $81.24 with intraday trading volume of 3.43 Million.

Over thepast week, GEHC stock reflected an impressive hike of more than 1.50%. Thehe price moved upwards by 3.44% over the past month.

The 52-weeks price target of GEHC stock is $89.25, around 9.86% higher than the current trading price. In the past 52 weeks, the stock’s highest traded price was$87.83, and the lowest traded price was $53.00.

The average trading volume of GEHC stock is 3.43 Million, and the company’s market capitalization is $3.556 Million. In the last two trading sessions – June 29 and June 30 – GE HealthCare Technology stock chart reflected the overwhelming presence of the buyers.

The company’s revenue constitutes 39% gross profit, 17% EBITDA, 14% EBIT and 10% EBT. Over 390 Million of GE HealthCare Technology shares are free-floating, and financial backers of the company and the board members closely hold the remaining 62.775 Million shares.

GE HealthCare Technology Earnings & Revenue

In Q1 2023, GE HealthCare Technology reported 1.58% more revenue than estimated revenue. Thehe company was expected to report $4.63 Billion in revenue (estimated), but surprisingly its investors’ company reported $4.71 Billion in revenue.

The estimated revenue was $4.63 Billion, but the investors were in for a pleasant surprise as the company reported $4.71 Billion, a ~1.73% difference.

As per estimates, GE HealthCare Technology might report $4.79 Billion in Q2 and $4.78 Billion in Q3. In Q1 2023, the Earning Per Share (EPS) of the company was 7.10% higher than the estimated EPS.

Most of the company’s revenue is generated from Ultrasound, Patient Care Solutions, Pharmaceutical Diagnostics, Healthcare Financial, and Imaging. GE HealthCare Technology primarily operates in the United States, China, and several other regions.

The company’s short-term assets are worth $7.82 Billion, and liabilities are worth $7.19 Billion. Moreover, in the long term, total assets of the company are worth $19.72 Billion and liabilities are worth $10.76 Billion. From the total generated revenue of Q1 2023, the company’s net income was $372.00 Million with a profit margin of 7.90%.

In the financial year 2022, GE HealthCare Technology generated $3.42 Billion from ultrasound, $2.92 Billion from Patient Care Solutions, $1.96 Billion from Pharmaceutical Diagnostics, $60.00 Million from Healthcare Financial, and $9.98 Billion from Imaging.

Around $7.82 Billion was generated in revenue from the United States, $2.33 Billion from China, and the remaining $8.20 Billion from other regions.

Disclaimer

The views and opinions stated by the author, or any people named in this article, are for informational ideas only and do not establish financial, investment, or other advice. Investing in or trading crypto assets comes with a risk of financial loss.

Andrew is a blockchain developer who developed his interest in cryptocurrencies while his post-graduation. He is a keen observer of details and shares his passion for writing along with being a developer. His backend knowledge about blockchain helps him give a unique perspective to his writing